Results 111 to 120 of about 41,213 (233)

Scientific production on the Mantel-Haenszel procedure as a way of detecting DIF.

Psicothema, 2009
ESP
Guilera Ferré, Georgina, Gómez Benito, Juana, Hidalgo Montesinos, María Dolores   +2 more
openaire   +2 more sources

Soticlestat as an adjunctive therapy in children and young adults with Dravet syndrome

Epilepsia, Volume 67, Issue 6, Page 2796-2807, June 2026.
Overview of the phase 3 trial evaluating soticlestat as adjunctive therapy in children and young adults with Dravet syndrome. Abstract Objective This study evaluated the efficacy, safety, and tolerability of soticlestat as adjunctive therapy in children and young adults with Dravet syndrome (DS).
Joseph Sullivan, Kette Valente, Vicente Villanueva, Adam Strzelczyk, Rima Nabbout, Eiji Nakagawa, Yuehua Zhang, Marta Zolnowska, Yasir Khan, Cheng Dong, Samuel Hsiao, Sarah I. Sheikh, Philipp von Rosenstiel, Mahnaz Asgharnejad, Venkatesha Murthy   +14 more
wiley   +1 more source

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract We report primary analysis results from the Phase 3 PERSPECTIVE study comparing ibrutinib + rituximab versus placebo + rituximab in patients with previously untreated follicular lymphoma requiring treatment per Groupe d'Etude des Lymphomes Folliculaires criteria who were ineligible for chemoimmunotherapy due to age and/or comorbidities.
David Belada, Faithlore P. Gardner, Ana C. de Oliveira, Juan‐Manuel Sancho, Elza Lomaia, David Wright, Mehmet Turgut, Elena Martynova, Zsolt Lázár, Bertrand Anz, Ming‐Chung Wang, Wojciech Legiec, Stephen Opat, Junvie Pailden, Hillary M. Peltier, Emerenziana Marturano, James P. Dean, Ian W. Flinn   +17 more
wiley   +1 more source

Computing single-, two-stage, and iterative Mantel-Haenszel statistics. [PDF]

Psicológica, 1999
Fidalgo A. M., G. J. Mellenbergh, J. Muñiz   +2 more
doaj  

Single‐Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT‐035 Study

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background Janus kinase inhibitors (JAKis), the current standard of care for myelofibrosis (MF), provide clinical benefit, but responses are frequently incomplete, non‐durable, and associated with cytopenias, underscoring the need for therapies with novel mechanisms of action.
Sebastian Grosicki, Habte Yimer, Rosa Ayala, Suning Chen, Hong Liu, Françoise Boyer, Paola Guglielmelli, Marco Brociner, Paolo Sportoletti, Gabor Mikala, Panagiotis Tsirigotis, Jin Zhang, Tomer Mark, Yi Chai, Andrea Ellero, Alessandro Lucchesi   +15 more
wiley   +1 more source

Hospital‐to‐home transition for children with asthma‐related hospitalizations: A study protocol for a pragmatic randomized controlled trial

Journal of Hospital Medicine, Volume 21, Issue 6, Page 700-709, June 2026.
Abstract Introduction Asthma is one of the most common chronic diseases of childhood with morbidity disproportionately affecting children across different racial and/or ethnic groups and socioeconomic statuses, specifically Black children and those living in poverty. Hospitalization for asthma is a significant risk factor for future readmissions.
Amy R. Law, Shilpa J. Patel, Janet A. Phoenix, Heather Gordish‐Dressman, Stephen J. Teach, Kavita Parikh   +5 more
wiley   +1 more source

Conducting Meta-Analyses in R with the metafor Package

Journal of Statistical Software, 2010
The metafor package provides functions for conducting meta-analyses in R. The package includes functions for fitting the meta-analytic fixed- and random-effects models and allows for the inclusion of moderators variables (study-level covariates) in these
Wolfgang Viechtbauer
doaj  

Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria

JEADV Clinical Practice, Volume 5, Issue 2, Page 529-537, June 2026.
ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won, Chun Wook Park, Jiyoung Ahn, Joo Yeon Ko, Sang Hyun Cho, Yang Won Lee, Joo Hee Lee, Khai Jing Ng, Min Young Hong, Jinglin Zhong, Martin Dossenbach, Sang Wook Son   +11 more
wiley   +1 more source

Estimating the Joint Probability Density for Index Construction: Some Simplifications Using the TWEAK as Example

International Journal of Methods in Psychiatric Research, Volume 35, Issue 2, June 2026.
ABSTRACT Background Index construction using the joint probability density (JPD) method is extremely robust and, unlike confirmatory factor analysis (CFA) or item response theory (IRT), puts few restrictions on underlying data. When input variables' numbers are large, however, JPD estimation can be difficult.
Maureen Murdoch, Barbara Ann Clothier, Siamak Noorbaloochi   +2 more
wiley   +1 more source

Authors' reply: Continuity corrections with Mantel-Haenszel estimators in Cochrane reviews. [PDF]

Res Synth Methods
Tsujimoto Y, Tsutsumi Y, Kataoka Y, Shiroshita A, Efthimiou O, Furukawa TA.   +5 more
europepmc   +1 more source